BUY Sudarshan Chemical Industries Limited — Rajesh Palviya, Axis Securities
Entry₹1,149Inferred
Stop loss₹1,090-5.13% risk
Exit₹1,09012 Aug 2026, 12:08 pm
Stop-loss hit-5.13%
Follow Rajesh Palviya for new callsGet alertsWatch SUDARSCHEM for new buy/sell callsGet alertsSee 5 active Long-term calls on SUDARSCHEM
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 supporting1 neutral0 opposing
Supports the BUY call (3)
3 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·20 Jul · 3w ago
Neutral / worth noting (1)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sudarshan Chemical Industries
- BUY — Kunal Saraogi1 Oct 2026 · ~2 weeks · target ₹1,265 · Target hit
- BUY — Axis Capital30 Sept 2026 · ~1 year · target ₹1,490 · Active
- BUY — Prakash Gaba18 Sept 2026 · ~2 weeks · target ₹1,275 · Target hit
- BUY — Dhvani Patel10 Sept 2026 · ~2 weeks · target ₹1,370 · SL hit
- BUY — Ruchit Jain, Motilal Oswal3 Sept 2026 · ~3 months · target ₹1,360 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit